Parkin N - Search Results

1

Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.

Parkin N, Harrigan PR, Inzaule S, Bertagnolio S. Parkin N, et al. PLOS Glob Public Health. 2023 Oct 18;3(10):e0001948. doi: 10.1371/journal.pgph.0001948. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37851634 Free PMC article. Review.

2

A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.

Resch W, Parkin N, Stuelke EL, Watkins T, Swanstrom R. Resch W, et al. Among authors: parkin n. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):176-81. doi: 10.1073/pnas.98.1.176. Proc Natl Acad Sci U S A. 2001. PMID: 11120887 Free PMC article.

3

Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis.

Parkin NT, Chiu P, Coelingh KL. Parkin NT, et al. Virus Res. 1996 Dec;46(1-2):31-44. doi: 10.1016/s0168-1702(96)01373-1. Virus Res. 1996. PMID: 9029775

4

Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistance.

Parkin NT, Chappey C, Petropoulos CJ. Parkin NT, et al. AIDS. 2003 May 2;17(7):955-61. doi: 10.1097/00002030-200305020-00003. AIDS. 2003. PMID: 12700444

5

Identification of a protein that binds specifically to RNA from the first exon of c-myc.

Parkin NT, Sonenberg N. Parkin NT, et al. Oncogene. 1989 Jul;4(7):815-22. Oncogene. 1989. PMID: 2502752

6

Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.

Roy S, Parkin NT, Rosen C, Itovitch J, Sonenberg N. Roy S, et al. Among authors: parkin nt. J Virol. 1990 Mar;64(3):1402-6. doi: 10.1128/JVI.64.3.1402-1406.1990. J Virol. 1990. PMID: 2406460 Free PMC article.

7

Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.

Johnson VA, Petropoulos CJ, Woods CR, Hazelwood JD, Parkin NT, Hamilton CD, Fiscus SA. Johnson VA, et al. Among authors: parkin nt. J Infect Dis. 2001 Jun 1;183(11):1688-93. doi: 10.1086/320697. Epub 2001 Apr 23. J Infect Dis. 2001. PMID: 11343221

8

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA. Deeks SG, et al. Among authors: parkin nt. J Infect Dis. 1999 Jun;179(6):1375-81. doi: 10.1086/314775. J Infect Dis. 1999. PMID: 10228057 Clinical Trial.

9

Activity of Wnt-1 as a transmembrane protein.

Parkin NT, Kitajewski J, Varmus HE. Parkin NT, et al. Genes Dev. 1993 Nov;7(11):2181-93. doi: 10.1101/gad.7.11.2181. Genes Dev. 1993. PMID: 8224845 Free article.

10

Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

Parkin NT, Cohen EA, Darveau A, Rosen C, Haseltine W, Sonenberg N. Parkin NT, et al. EMBO J. 1988 Sep;7(9):2831-7. doi: 10.1002/j.1460-2075.1988.tb03139.x. EMBO J. 1988. PMID: 3181141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters